NRx Pharmaceuticals Receives FDA Approval of Preservative-Free Ketamine, to Be Made in West Columbia
November 2, 2026
On October 30, 2026, our partners at NRx Pharmaceuticals announced FDA approval of their preservative-free ketamine. The product will be manufactured with Nephron at our campus in West Columbia, South Carolina.
From NRx’s announcement:
“NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) … today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Abbreviated New Drug Application (ANDA) for Preservative-Free Ketamine.”
“We are pleased to work with our partners at Nephron Pharmaceuticals in West Columbia, South Carolina, who have helped us prove that sterile, preservative-free injectables can be made in America.” – Jonathan Javitt, MD, MPH, Chairman and CEO, NRx Pharmaceuticals
Congratulations to the NRx team. We’re proud to be part of this work.
Read NRx’s full release: https://ir.nrxpharma.com/news-releases/news-release-details/nrx-pharmaceuticals-nasdaqnrxp-receives-fda-approval
